Skip to the story
All stories

Bayer to build $2.2bn Ohio plant creating 600 jobs

The pharmaceutical company announced plans for a new manufacturing site in New Albany, Ohio.

AI-assisted coverage comparison, editor-supervised · How this was made

Published Updated
Bayer to build $2.2bn Ohio plant creating 600 jobs

What this story says

  • Bayer announced a $2.2 billion investment in a new pharmaceutical manufacturing site in New Albany, Ohio.
  • The facility is projected to create around 600 high-value jobs and approximately 1,500 construction jobs.
  • The first part of the plant is scheduled to begin operations in 2031, with a second module planned for 2034.
  • This investment is part of Bayer's strategy to expand its pharmaceutical business and patient access in the US.

Who covered it

Left 13%(4)Centre 48%(15)Right 39%(12)

Percentages are shares of the 31 outlets carrying a published leaning rating. 39 of the 70 outlets we know ran this story carry no rating and are not counted in them. Coverage measured .

Trust

60/100

Craft

60/100

Hype

20/100

70 sources · methodology

Missing from the left

Only 4 of the 31 outlets with a published leaning rating that ran this story are rated left.

A reader who follows the left would not have seen this. We report the absence rather than explain it: outlets choose what to cover for many reasons, and we have no evidence about which one applies here.

Bayer plans to invest $2.2 billion in a new pharmaceutical manufacturing site in New Albany, Ohio. The company announced the project on 2 October 2026, stating it is part of a long-term growth strategy and commitment to innovation and patient access in the US. The new facility is expected to create approximately 600 high-value jobs and around 1,500 construction jobs. The first module of the site, dedicated to drug substance manufacturing, is anticipated to become operational in 2031, with a second module for drug product manufacturing planned for 2034.

Coverage disagreements

One report stated that the new facility would be built in the New Albany International Business Park, while another mentioned it would be located in the New Albany International Business Park, part of the Columbus Region. The Manila Times reported that the project will pursue a Job Creation Tax Credit from the Ohio Department of Development and may seek JobsOhio assistance, with details to be made public after a final agreement. Other reports did not mention these specific details regarding tax credits or assistance.

What the coverage left out

None of the right-rated reports mention the Ohio Life Science Training Center, which Bayer will draw on to train workers. The centre-rated reports also omit details about the specific types of drugs to be manufactured at the facility, such as oncology, cardiovascular, and renal care products, as well as the flexible, modular design of the campus.

Coverage settled. We checked this 8 times and stopped on 8 Oct 2026, 01:30. The figures above are what it finished at.

How each side covered it

Our own reading of the reporting listed below, written from the outlets’ articles rather than quoted from them. The reasoning is set out on our methodology page.

Left

4 rated outlets

  • All three left‑rated outlets reported that Bayer intends to invest roughly $2.2 billion in a new pharmaceutical manufacturing site in New Albany, Ohio, creating about 600 permanent positions and around 1,500 construction jobs. The core facts of investment size, location and job numbers are consistent across the digests.
  • Zeit Online’s digest highlighted that the investment exceeds $2 billion, SANA’s digest specified a $2.2 billion outlay for a new pharmaceutical facility, and WOSU Public Media’s digest foregrounded the 600 permanent jobs together with 1,500 construction roles. No direct quotations or external voices appear in any of the three digests.
  • None of the left‑rated digests include commentary on local community response, environmental considerations, project timelines, or statements from Bayer or local officials. Their coverage is limited to the financial commitment, site location and employment figures, leaving those additional aspects unreported.

Centre

15 rated outlets

  • The centre-rated reports led on Bayer's announcement of a $2.2 billion investment in a new US pharmaceutical manufacturing site. They noted the creation of approximately 600 high-value jobs and roughly 1,500 construction jobs. Both reports mentioned that the first module of the facility is expected to be operational in 2031, with a second module planned for 2034. The investment is described as part of Bayer's strategy to boost its US revenue and business.

Right

12 rated outlets

  • The right-rated reports highlighted Bayer's $2.2 billion investment in a new manufacturing site in Ohio. They noted the creation of around 600 high-value jobs and approximately 1,500 construction jobs. One report mentioned that cancer, heart, and kidney drugs would be produced there, strengthening Bayer's US business. Another report linked the investment to US President Donald Trump's efforts to combat high drug prices, suggesting pharmaceutical companies are building factories in the US to appease him. The Manila Times, which provided a full report, included statements from Ohio Governor Mike DeWine, Bayer CEO Bill Anderson, and Senator Bernie Moreno, and detailed the workforce readiness and infrastructure supporting the project.

Questions about this coverage

How did the left and right cover Bayer to build $2.2bn Ohio plant creating 600 jobs?
Of the 31 outlets on this story carrying a published leaning rating, 13% are rated left, 48% are rated centre, 39% are rated right. Those percentages are shares of the rated outlets, not of every outlet that ran it, which was 70. The sections above set out what each side emphasised, in its own terms.
Is Bayer to build $2.2bn Ohio plant creating 600 jobs left or right?
Neither side dominates it. Of the 31 rated outlets on this story, 13% are rated left, 48% are rated centre, 39% are rated right, and no side holds the 70% this site would want before calling a field one-sided. A story is not left or right in any case; the outlets that carried it are what carry ratings.
Is the coverage of Bayer to build $2.2bn Ohio plant creating 600 jobs biased?
Bayer to build $2.2bn Ohio plant creating 600 jobs is one event reported by 70 outlets, and this page does not rate the story as biased or unbiased. What it publishes is the spread: which outlets ran it, where named rating organisations place each of them on the spectrum, and what each side chose to lead with. A leaning rating describes an outlet's record over time, not this article, and the two should not be run together.
Which side is not reporting Bayer to build $2.2bn Ohio plant creating 600 jobs?
When we first saw this story, outlets rated left had barely covered it. Coverage accretes for hours after an event, so that is where to look rather than a verdict — the split above is the current count, and it is the one to read.
Which outlets covered Bayer to build $2.2bn Ohio plant creating 600 jobs?
70 that we know of, every one of them listed further up this page with a link to its own report and to what we hold on the publisher. Nothing here is a summary of somebody else's summary: the outlets are named so the original reporting can be read.
How much is Bayer investing in the new Ohio facility?
Bayer is investing $2.2 billion in a new pharmaceutical manufacturing site in New Albany, Ohio. This investment is part of the company's long-term strategy to grow its pharmaceutical business and enhance patient access in the United States.
How many jobs will the new Bayer facility create?
The new Bayer facility is expected to create approximately 600 high-value jobs and around 1,500 construction jobs. These roles will support the manufacturing and operation of the pharmaceutical site.
When will the new Bayer plant become operational?
The first module of the Bayer manufacturing site, focused on drug substance production, is scheduled to become operational in 2031. A second module for drug product manufacturing is planned to follow in 2034.

Read it at the source

70 outlets, grouped by the leaning a published rating gives them. Every headline links to the original; an underlined outlet name opens our profile of that publisher.

Left

4

Centre

15
Show 7 more

Right

12
Show 4 more

Not rated

39
Show 31 more

How did this read?

About the coverage, not about the story. We do not ask whether you agree with what happened — we have no honest use for that answer.

Bayer Ohio plant investment | MediaBias News